英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
2-(10-Oxo-10,11-dihydrodibenzo[b,f]thiepin-2-yl)propanoic acid
|
74711-43-6 |
扎托布洛芬
|
托布洛芬;10,11-二氢-alpha-甲基-10-氧代-二苯并[b,f]硫卓-2-乙酸;扎托布洛芬;CN100;SOLETON;CN-100;CN 100;扎托布洛芬
|
C17H14O3S |
298.36 | 277-973-5 |
zafirlukast
|
107753-78-6 |
扎鲁司特
|
[3-[[2-甲氧基-4-[[[(2-甲基苯基)磺酰基]氨基]羰基]苯基]甲基]-1-甲基-1H-吲哚-5-基]氨基甲酸环戊基酯;扎夫司特;ZAFIRLUCAST;印度 THYKN;扎鲁司特;扎鲁斯特;[3-[2-甲氧基-4-[(2-甲苯基)磺酰胺基甲酰基]苄基]-1-甲基-吲哚-5-基]氨基甲酸环戊酯
|
C31H33N3O6S |
575.68 | |
XL 388
|
1251156-08-7 |
[7-(6-氨基-3-吡啶基)-2,3-二氢-1,4-苯并氧氮杂卓-4(5H)-基][3-氟-2-甲基-4-(甲基磺酰基)苯基]-甲酮
|
XL-388;XL 388;[7-(6-氨基-3-吡啶基)-2,3-二氢-1,4-苯并氧氮杂卓-4(5H)-基][3-氟-2-甲基-4-(甲基磺酰基)苯基]-甲酮;CS-772
|
C23H22FN3O4S |
455.5018832 | |
WZ4003
|
1214265-58-3 |
WZ43
|
CS-1174;WZ 4003;WZ4003;N-[3-[[5-氯-2-[[2-甲氧基-4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氧基]苯基]丙酰胺
|
C25H29ClN6O3 |
496.98916 | |
WZ4002
|
1213269-23-8 |
WZ42
|
N-[3-[[5-氯-2-[[2-甲氧基-4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氧基]苯基]-2-丙烯酰胺;WZ4002(表皮生长因子受体抑制剂);WZ4002(溴化氢盐);WZ4002(N-[3-[[5-氯-2-[[2-甲氧基-4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氧基]苯基]-2-丙烯酰胺);N-(3-((5-氯-2-((2-甲氧基-4-(4-甲基哌嗪-1-基)苯基)胺)嘧啶-4-基)氧)苯基)丙烯酰胺;WZ4002;WZ 4002;WZ-4002;CS-166
|
C25H27ClN6O3 |
494.99 | |
WYE-687
|
1062161-90-3 |
N-[4-[4-(4-吗啉基)-1-[1-(3-吡啶甲基)-4-哌啶基]-1H-吡唑并[3,4-D]嘧啶-6-基]苯基]氨基甲酸甲酯
|
CS-540;N-[4-[4-(4-吗啉基)-1-[1-(3-吡啶甲基)-4-哌啶基]-1H-吡唑并[3,4-D]嘧啶-6-基]苯基]氨基甲酸甲酯;WYE-687;WYE 687;WYE687
|
C28H32N8O3 |
528.60548 | |
WYE-354
|
1062169-56-5 |
4-[6-[4-[(甲氧羰基)氨基]苯基]-4-(4-吗啉基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶羧酸甲酯
|
4-[6-[4-[(甲氧羰基)氨基]苯基]-4-(4-吗啉基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶羧酸甲酯;WYE-354;WYE 354; WYE354;CS-441
|
C24H29N7O5 |
495.53096 | |
WYE-125132 (WYE-132)
|
1144068-46-1 |
N-[4-[1-(1,4-二氧杂螺[4.5]癸烷-8-基)-4-(8-氧杂-3-氮杂双环[3.2.1]辛烷-3-基)-1H-吡唑并[3,4-D]嘧啶-6-基]苯基]-N'-甲基脲
|
WYE-125132;WYE 125132;N-[4-[1-(1,4-二氧杂螺[4.5]癸烷-8-基)-4-(8-氧杂-3-氮杂双环[3.2.1]辛烷-3-基)-1H-吡唑并[3,4-D]嘧啶-6-基]苯基]-N'-甲基脲;1-(4-(4-(8-噁-3-氮杂双环[3.2.1]-3-辛基)-1-(1,4-二噁螺[4.5]-8-癸基)-1H-吡唑并[3,4-D]嘧啶-6-基)苯基)-3-甲基脲;WYE-125132 (WYE-132);WYE-125132;WYE 125132;WYE125132
|
C27H33N7O4 |
519.59542 | |
WP1130 ( Degrasyn )
|
856243-80-6 |
(2E)-3-(6-溴-2-吡啶基)-2-氰基-N-[(1S)-1-苯基丁基]-2-丙烯酰胺
|
(2E)-3-(6-溴-2-吡啶基)-2-氰基-N-[(1S)-1-苯基丁基]-2-丙烯酰胺
|
C19H18BrN3O |
384.28 | |
Wortmannin
|
19545-26-7 |
渥曼青霉素
|
CS-731;SL-2052;KY-12420;WORTMANNIN 渥曼青霉素;抗生素SL-2052;渥曼青霉素,一种多靶点抑制剂,抑制PI3K和MLCK;渥曼青霉素,来源于黄色;渥曼青霉素;沃氏篮酶素
|
C23H24O8 |
428.43 | 606-337-5 |
WAY-600
|
1062159-35-6 |
6-(1H-吲哚-5-基)-4-(4-吗啉基)-1-[1-(3-吡啶基甲基)-4-哌啶基]-1H-吡唑并[3,4-D]嘧啶
|
6-(1H-吲哚-5-基)-4-(4-吗啉基)-1-[1-(3-吡啶基甲基)-4-哌啶基]-1H-吡唑并[3,4-D]嘧啶
|
C28H30N8O |
494.5908 | |
Vilazodone Hydrochloride
|
163521-08-2 |
盐酸维拉唑酮
|
盐酸维拉唑酮;维拉唑酮中间体2;盐酸维拉佐酮及中间体;盐酸维拉唑酮 API;5-(4-[4-(5-氰基-1H-吲哚-3-基)丁基]哌嗪-1-基)苯并呋喃-2-甲酰胺盐酸盐;CS-796;维拉佐酮盐酸盐 1KG
|
C26H28ClN5O2 |
477.98582 | 695-883-8 |
Verteporfin
|
129497-78-5 |
维替泊芬
|
维替泊芬;微替泊芬;维替铂芬;VERTEPIRFIN;9-甲基 (异构体1)13-甲基(异构体2)反式-(±)-18-乙烯基-4,4A-二氢-3,4 –二(甲氧羰基)-4A,8,14,19-四甲基-23H,25H-苯并[B]卟吩-9,13-二丙酸酯;维替卟吩
|
2C41H42N4O8 |
1437.61 | |
Vatalanib di hydrochloride
|
212141-51-0 |
瓦他拉尼
|
N-(4-氯苯基)-4-(4-吡啶甲基)-1-酞嗪胺二盐酸盐;瓦他拉尼二盐酸盐;瓦他拉尼;瓦他拉尼碱二盐酸盐;瓦他拉尼(PTK787 )2HCL
|
C20H17Cl3N4 |
419.74 | |
UPF 1069
|
1048371-03-4 |
5-(2-氧代-2-苯基乙氧基)-1(2H)-异喹啉酮
|
5-(2-氧代-2-苯基乙氧基)-1(2H)-异喹啉酮
|
C17H13NO3 |
281 | |
19-Norpregna-4,9-diene-3,20-dione,11-[4-(dimethylamino)phenyl]-17-hydroxy-,(11β)-
|
159811-51-5 |
醋酸乌利司他中间体
|
埃拉片杂质;20-二酮(中八);醋酸乌利司他中间体;9-二烯-3;N-二甲基氨基)-苯基]-17Α-羟基-19-去甲孕甾-4;11Β-[4-(N,N-二甲基氨基)-苯基]-17Α-羟基-19-去甲孕甾-4,9-二烯-3,20-二酮(中八);11Β-[4-(N,20-二酮;醋酸乌利司他中间体四
|
C28H35NO3 |
433.5824 | 815-032-8 |
U0126-EtOH
|
1173097-76-1 |
2,3-双[氨基[(2-氨基苯基)硫]亚甲基]丁二腈乙醇盐
|
u 126;2,3-bis(amino(2-aminophenylthio)methylene)succinonitrile,ethanol;(2Z,3Z)-2,3-bis[amino-(2-aminophenyl)sulfanylmethylidene]butanedinitrile,ethanol;(2Z,3Z)-2,3-Bis(amino(2-aminophenylthio)methylene)succinonitrile compound with ethanol (1:1);U0126-EtOH;2,3-Bis[amino[(2-aminophenyl)thio]methylene]butanedinitrile ethanol salt;U0126-EtOH, 98%, a high selective MEK1/2 inhibitor;U0126 Ethanol
|
C18H16N6S2.C2H6O |
||
TW-37
|
877877-35-5 |
N-[4-(2-叔丁基苯磺酰基)苯基]-2,3,4-三羟基-5-(2-异丙基苯基甲基)苯甲酰胺
|
4-三羟基-5-(2-异丙基苯基甲基)苯甲酰胺;N-[4-(2-叔丁基苯磺酰基)苯基]-2;CS-299;TW37;TW 37;N-[4-(2-叔丁基苯磺酰基)苯基]-2,3,4-三羟基-5-(2-异丙基苯基甲基)苯甲酰胺;N-[4-(2-叔丁基苯磺酰基)苯基]-2,4-三羟基-5-(2-异丙基苯基)苯甲酰胺;N-[4-(2-叔丁基苯磺酰基)苯基]-2,4-三羟基-5-(2-异丙基苄基)苯甲酰胺
|
C33H35NO6S |
573.6991 | |
Tubacin
|
537049-40-4 |
HDAC6 抑制剂
|
HDAC6 抑制剂
|
C41H43N3O7S |
721.88 | |
troxipide
|
30751-05-4 |
曲昔匹特
|
曲昔派特;曲昔吡特;曲昔匹特.曲昔派特.拉氧头孢;3,4,5-三甲氧基-N-(3-哌啶基)苯甲酰胺;曲昔匹特;曲昔派特;5-三甲氧基-N-(3-哌啶基)苯甲酰胺;曲昔吡特 98.6% MIN;曲西匹特
|
C15H22N2O4 |
294.35 | 805-913-5 |